Related Experiment Videos
Cardiac matrix alterations induced by adriamycin
1Department of Pathology, University of Alabama, Birmingham.
Abstract:
Adriamycin is toxic to humans and animals and causes cardiac lesions involving myocytes and the interstitial tissue. The present study used a single injection of adriamycin in rats. Focal loss of myocardial interstitial collagen occurred 2 weeks after a single injection of adriamycin. These foci become larger and more frequent through 6 weeks. Individual variation in response is evident after periods longer than 6 weeks. Concomitant with the focal loss is deposition of collagen in an abnormal distribution. Rather than the normal matrix being present, scars appear. The number and size of these scars is subject to variation from animal to animal. The collagen matrix loss is evident in some animals at 15 weeks after injection. These observations, coupled with the results of other studies on the myocardial collagen matrix, support the hypothesis that adriamycin cardiotoxicity is mediated in part by an affect on the collagen matrix.
Insights
Adriamycin causes cardiac damage by affecting the collagen matrix in heart tissue. This study shows adriamycin-induced collagen loss and scarring in rat hearts, supporting its role in cardiotoxicity.
Area of Science:
- Cardiology
- Toxicology
- Biochemistry
Background:
- Adriamycin (doxorubicin) is a widely used chemotherapy agent.
- Adriamycin is known to cause cardiotoxicity, affecting heart muscle (myocytes) and interstitial tissue.
- The precise mechanisms underlying adriamycin cardiotoxicity are not fully understood.
Purpose of the Study:
- To investigate the effects of adriamycin on the myocardial collagen matrix in a rat model.
- To determine if adriamycin-induced changes in collagen correlate with cardiotoxicity.
Main Methods:
- A single injection of adriamycin was administered to rats.
- Myocardial tissue was analyzed at various time points post-injection (2, 6, and 15 weeks).
- Changes in collagen distribution and the formation of scar tissue were assessed.
Main Results:
- Focal loss of myocardial interstitial collagen was observed starting at 2 weeks post-injection.
- These collagen-deficient areas enlarged and became more frequent by 6 weeks.
- Abnormal collagen deposition led to the formation of scar tissue, with individual variations in size and number.
- Collagen matrix loss was still evident in some animals at 15 weeks.
Conclusions:
- Adriamycin significantly alters the myocardial collagen matrix.
- The observed collagen loss and scar formation support the hypothesis that adriamycin cardiotoxicity involves damage to the cardiac collagen matrix.
- These findings contribute to understanding the pathogenesis of adriamycin-induced heart damage.